Literature DB >> 26674503

Bushehr Elderly Health (BEH) Programme, phase I (cardiovascular system).

Afshin Ostovar1, Iraj Nabipour2, Bagher Larijani3, Ramin Heshmat4, Hossein Darabi1, Katayoun Vahdat1, Maryam Ravanipour1, Neda Mehrdad5, Alireza Raeisi1, Gholamreza Heidari1, Gita Shafiee4, Mohammadjavad Haeri1, Mohammadreza Pourbehi2, Farshad Sharifi5, Azita Noroozi1, Rahim Tahmasebi1, Hamidreza Aghaei Meybodi6, Majid Assadi7, Shokrollah Farrokhi7, Reza Nemati7, Mohammad Reza Amini3, Maryam Barekat1, Abdullatif Amini1, Houman Salimipour1, Sina Dobaradaran2, Darab Moshtaghi1.   

Abstract

PURPOSE: The main objective of the Bushehr Elderly Health Programme, in its first phase, is to investigate the prevalence of cardiovascular risk factors and their association with major adverse cardiovascular events. PARTICIPANTS: Between March 2013 and October 2014, a total of 3000 men and women aged ≥ 60 years, residing in Bushehr, Iran, participated in this prospective cohort study (participation rate=90.2%). FINDINGS TO DATE: Baseline data on risk factors, including demographic and socioeconomic status, smoking and medical history, were collected through a modified WHO MONICA questionnaire. Vital signs and anthropometric measures, including systolic and diastolic blood pressure, weight, height, and waist and hip circumference, were also measured. 12-lead electrocardiography and echocardiography were conducted on all participants, and total of 10 cc venous blood was taken, and sera was separated and stored at -80 °C for possible future use. Preliminary data analyses showed a noticeably higher prevalence of risk factors among older women compared to that in men. FUTURE PLANS: Risk factor assessments will be repeated every 5 years, and the participants will be followed during the study to measure the occurrence of major adverse cardiac events. Moreover, the second phase, which includes investigation of bone health and cognition in the elderly, was started in September 2015. Data are available at the Persian Gulf Biomedical Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran, for any collaboration. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Mesh:

Year:  2015        PMID: 26674503      PMCID: PMC4691780          DOI: 10.1136/bmjopen-2015-009597

Source DB:  PubMed          Journal:  BMJ Open        ISSN: 2044-6055            Impact factor:   2.692


This is the first large sample prospective cohort study in Iran focusing on cardiovascular risk factors in the elderly as a growing population. The long-term follow-up in this study will allow for the assessment of many relevant outcomes. The participation rate in this study was high; however, outcome ascertainment may be incomplete because of incomplete death and MACE registries.

Introduction

The world's population is ageing rapidly. The proportion of those over the age of 60 years will double, from about 11% to 22%, between 2000 and 2050. The absolute number of people aged 60 years and over is expected to increase from 605 million to 2 billion over the same period.1 According to the latest Iranian Census Data, about 8.2% of the population was over 60 years of age in 2011.2 By the year 2020, the elderly population (over 60 years of age) is estimated to reach 10%. Coronary heart disease (CHD) is one of the leading causes of disease burden in developing countries. In other words, three-fourths of global deaths due to CHD occurred in low-income and middle-income countries.3 In the year 2003, there were 21 572 Disability Adjusted Lost Years (DALYs) due to all diseases and injuries per 100 000 Iranian people of all ages and both sexes. From this total number of DALYs, 58% were due to non-communicable diseases; ischaemic heart disease was the fourth cause of DALYs in males and the first cause of DALYs in females.4 There is a need for effective public health action on cardiovascular disease (CVD) prevention, especially in low-income and middle-income countries, and for assessments of the cost-effectiveness of feasible interventions.5 In addition, there is a need to try to balance the fight against the existing burden of infectious diseases with the growing epidemic of chronic diseases such as heart disease and diabetes.6 The high costs of direct medical care and the indirect costs of CVD, according to the American Heart Association, were approaching $450 billion annually in 2010 and were projected to rise to over $1 trillion annually by 2030.7 Prevention of premature deaths due to non-communicable diseases and the reduction of related healthcare costs should be the main goals of health policy. Improving the detection and treatment of non-communicable diseases, and preventing complications and catastrophic events from occurring, should be the major goals of clinical medicine.8 Trends in CVD risk factors and blood glucose will result in substantial CVD burden in developing countries and economies in transition in the near future. Periodic and consistent monitoring of trends and the effects of these risk factors on disease burden is needed for prioritising prevention programmes.9 In recent decades, cohort studies have played a major role in investigating the incidence and causes of common health outcomes. As major adverse cardiovascular events (MACE) are quite common in old age, there are many cohort studies investigating these outcomes. A vast majority of these cohort studies are being conducted in developed countries.10–20 However, the number of such prospective studies in the developing world is also rising.21–25 In Iran, there are a few large prospective studies being conducted in various fields. Golestan's cohort study, a prospective study of oesophageal cancer in northern Iran,26 the Tehran Lipid and Glucose Study (TLGS)27 and the Shahrood Eye Cohort Study (ShECS),28 are among these studies. The Amirkola Health and Ageing Project (AHAP) is the only large sample prospective cohort study in Iran, specifically aimed at investigating falling, bone fragility and fractures, cognitive impairment and dementia, poor mobility and functional dependence in the elderly.29 This paper describes the rationale for, design and preliminary results of the Bushehr Elderly Health (BEH) Programme, a population-based prospective cohort study conducted in Bushehr, a southern province of Iran. The main objective of this study, in its first phase, is to investigate the prevalence of cardiovascular risk factors and their association to MACE.

Cohort description

The target population of this prospective cohort study was all men and women aged 60 years and over residing in the city of Bushehr. Based on the information available from the Bushehr District Health Centre, this population was estimated to be around 10 000. Box 1 shows eligibility criteria for participation in the study. Inclusion criteria Age more than or equal to 60 years Both sexes Residency in Bushehr port since at least 1 year prior to the recruitment No plan to leave Bushehr for the following 2 years after the recruitment Adequate physical and mental ability to participate in the evaluation programme Signing of written informed consent Exclusion criteria No residence in Bushehr Unwilling to participate in the study The participants in the BEH Programme were selected through a multistage, stratified cluster random sampling method. Based on the classifications made by the municipality, as shown in figure 1, we stratified Bushehr to 75 strata. Numbers were assigned to the blocks (as clusters) of each stratum and then randomly sorted. We invited all eligible older people residing in each block selected to participate and then moved to the next block, repeating the invitation process, until we gained the sample required for that stratum. Sample sizes for strata were determined proportional to the number of households residing in each stratum. As shown in figure 2, between March 2013 and October 2014, from among 3297 older people aged 60 years and over who were invited, a total of 3000 participated in this study (participation rate: 91.0%). Non-respondents were found among all strata, and there was no obvious pattern indicating selection bias. Baseline characteristics of participants are shown in table 1.
Figure 1

Map of Bushehr and distribution of participants in the strata.

Figure 2

Flow chart of enrolments.

Table 1

Baseline sociodemographic characteristics of participants in Bushehr Elderly Health Programme

Characteristics (N (%))Men (1455 (48.5))Women (1545 (51.5))
Age group (years)
 ≤64616 (42.3)674 (43.6)
 65–69317 (21.8)378 (24.5)
 70–74230 (15.8)200 (12.9)
 75–79166 (11.4)181 (11.7)
 ≥80126 (8.7)112 (7.2)
Marital status
 Single5 (0.3)20 (1.3)
 Married1378 (94.7)884 (57.2
 Widowed68 (4.7)619 (40.1)
 Divorced4 (0.3)22 (1.4)
Current occupation
 Employed133 (9.1)23 (1.5)
 Retired1195 (82.1)126 (8.2)
 Unemployed*127 (8.7)1396 (90.4)
Education
 No education315 (21.6)777 (50.3)
 Primary school400 (27.5)459 (29.7)
 Secondary School276 (19.0)151 (9.8)
 High school287 (19.7)125 (8.1)
 University177 (12.2)33 (2.1)

*Homemaker for female.

Baseline sociodemographic characteristics of participants in Bushehr Elderly Health Programme *Homemaker for female. Map of Bushehr and distribution of participants in the strata. Flow chart of enrolments. The main follow-up assessments of risk factors will be carried out every 5 years for three consecutive periods (a total of 15 years of follow-up), in which all assessments will be repeated with comparable methods and modalities. In addition, interim assessments will be made to ascertain outcomes and risk factor changes. All participants will be contacted by a trained nurse once annually, and a checklist will be completed to check if any outcome of interest (major adverse cardiac events) has occurred during the 12 months prior to the assessment. A form has also been distributed to the participants to self-report as soon as possible after the occurrence of any of the targeted outcomes. Focal points in the two main hospitals in Bushehr (Shohadaye-Khalij-e-Fars and Salman-e-Farsi hospitals) are responsible for monthly checking of the hospital information system (HIS) and reporting admissions. If any outcome is reported, a general physician will review the inpatient/outpatient medical records and documents, and detailed information will be entered into the special outcome forms. Our database will be cross-linked with the death registry system database, available via the public health system. The death registry system receives information from hospitals, forensic medicine departments, cemeteries and vital events records offices, and duplicate records are deleted. The International Classification of Diseases (ICD) 10, WHO online version, is used to classify causes of death. A person's national identification number is used as a unique identifier to cross-link databases. In the case of a death report but no reliable death certificate, a verbal autopsy will be performed to determine cause of death. Box 2 presents list of outcomes ascertained in the present study. Death Myocardial infarction Stroke Cardiac interventions Hospital admission

Baseline examination

A modified WHO MONICA questionnaire30 translated into Persian was used as the core questionnaire to gather baseline information on demographic and socioeconomic variables and risk factors. Table 2 presents the components of the core questionnaire.
Table 2

Section and topics of the Core Questionnaire in the Bushehr Elderly Health Programme study

Type of dataComponents
Demographic▸ Personal information (name, nickname, surname)▸ National identification number▸ Age and sex▸ Marital status▸ Contact information
Socioeconomic▸ Employment status▸ Education level▸ Insurance▸ Family income▸ Family assets▸ Residence status
Cardiovascular risk factors and medical history▸ Smoking status and history▸ Physical activity▸ Menstrual and menopause history
▸ Blood pressure history▸ Diabetes history▸ Lipid profile history▸ Ischaemia and myocardial infarction history▸ Weakness, impaired sensation and stroke history▸ Rose and claudication history▸ Heart failure history
Drug history▸ Administered by physician▸ Over the counter drugs▸ Supplements
Section and topics of the Core Questionnaire in the Bushehr Elderly Health Programme study

Phlebotomy and laboratory analyses

Participants were asked to provide a venous blood sample for laboratory tests. A total of 10 cc of whole blood was taken by a trained nurse after 8–12 h of fasting. Table 3 presents laboratory tests performed at baseline and their methods of measurement. Sera were also separated and stored at –80°C for possible future use.
Table 3

Baseline physical examinations and laboratory tests, Bushehr Elderly Health Programme study

ItemMethod of measurement
Physical examination
 Arterial blood pressureManually by standard mercury sphygmomanometer in sitting position
 Weight in kgStadiometer; heavy outer garments will be removed
 Height in cmStadiometer; shoes will be removed
 Waist circumference in cmAt the midway level between the costal margins and the iliac crests
 Hip circumference in cmAt the level of the greater trochanters
Laboratory tests
 CBCAutomated haematology analyser
 Fasting blood sugarenzymatic (glucose oxidase) colourimetric method using a commercial kit (Pars Azmun Inc, Tehran, Iran)
 Lipid profile (total cholesterol, LDL-C, HDL-C, triglyceride)Serum total cholesterol and HDL cholesterol will be measured using a cholesterol oxidase phenol aminoantipyrine and triglycerides using a glycerol-3-phosphate oxidase phenol aminoantipyrine enzymatic method. Serum LDL cholesterol will be calculated using the Friedwald formula; LDL cholesterol will not be calculated when triglycerides concentration is >400 mg/dL
Procedures
 Electrocardiography12-lead, by a trained nurse
 EchocardiographyUsing M-Turbo Ultrasound System, Manufactured by SonoSite, Inc, by a cardiologist

CBC, complete blood count; HDL, high-density lipoprotein; LDL, low-density lipoprotein.

Baseline physical examinations and laboratory tests, Bushehr Elderly Health Programme study CBC, complete blood count; HDL, high-density lipoprotein; LDL, low-density lipoprotein.

Clinical assessment

A comprehensive physical examination, including vital signs, weight and height measurements, and waist and hip circumference, were taken at baseline. Twelve-lead electrocardiography, performed by a trained nurse, and echocardiography, carried out by a cardiologist, were conducted for all participants (see table 3).

Findings to date

Baseline data are being analysed, and preliminary findings are presented in table 4.31 The prevalence of cardiovascular risk factors was remarkably higher among older women compared to that in men. Smoking behaviour was different among older men and women. Older women did not smoke cigarettes as often as men; however, the prevalence of hookah smoking was higher in women. One-third of older women were obese, which was two times more than the prevalence of obesity among men. Metabolic syndrome was also about two times more prevalent among older women.
Table 4

Frequency and age-adjusted proportions of risk factors in participants of the Bushehr Elderly Health Programme

Risk factor (N (%))Men (1455 (48.5))Women (1545 (51.5))
Smoking
 Hookah
  Non-smoker1143 (78.8)951 (61.4)
  Current smoker110 (7.5)267 (17.2)
  Intermittent smoker4 (0.3)7 (0.5)
  Former smoker198 (13.4)320 (20.9)
 Cigarette
  Non-smoker1023 (70.3)1522 (98.5)
  Current smoker198 (13.7)14 (0.9)
  Intermittent smoker1 (0.1)0 (0.0)
  Former smoker233 (16.0)9 (0.6)
Hypertension820 (56.1)1054 (68.4)
Diabetes mellitus390 (27.0)506 (32.6)
Hypercholesterolaemia886 (61.0)1034 (66.9)
BMI*
 <25615 (42.6)414 (27.8)
 25–29.9612 (42.7)591 (39.0)
 ≥30211 (14.7)511 (33.2)
Metabolic syndrome†403 (28.5)826 (53.3)

*Forty-six missing.

†Based on the NCEP ATP III.

‡Percentages are age-adjusted.

BMI, body mass index.

Frequency and age-adjusted proportions of risk factors in participants of the Bushehr Elderly Health Programme *Forty-six missing. †Based on the NCEP ATP III. ‡Percentages are age-adjusted. BMI, body mass index.

Strengths and limitations

This is the first large sample prospective cohort study in Iran focusing on cardiovascular risk factors in the elderly as a growing population. The long-term follow-up in this study will allow for the assessment of many relevant outcomes. The participation rate in this study was high; however, outcome ascertainment may be incomplete because of incomplete death and MACE registries.
  28 in total

Review 1.  Global cardiovascular health promotion and disease prevention: 2011 and beyond.

Authors:  Darwin R Labarthe; Sandra B Dunbar
Journal:  Circulation       Date:  2012-05-29       Impact factor: 29.690

2.  Cohort profile: the Metropolit 1953 Danish male birth cohort.

Authors:  Merete Osler; Rikke Lund; Margit Kriegbaum; Ulla Christensen; Anne-Marie Nybo Andersen
Journal:  Int J Epidemiol       Date:  2005-12-23       Impact factor: 7.196

3.  Cohort profile: the Norwegian Mother and Child Cohort Study (MoBa).

Authors:  Per Magnus; Lorentz M Irgens; Kjell Haug; Wenche Nystad; Rolv Skjaerven; Camilla Stoltenberg
Journal:  Int J Epidemiol       Date:  2006-08-22       Impact factor: 7.196

4.  Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association.

Authors:  William S Weintraub; Stephen R Daniels; Lora E Burke; Barry A Franklin; David C Goff; Laura L Hayman; Donald Lloyd-Jones; Dilip K Pandey; Eduardo J Sanchez; Andrea Parsons Schram; Laurie P Whitsel
Journal:  Circulation       Date:  2011-07-25       Impact factor: 29.690

5.  Arterial stiffness and cardiovascular events: the Framingham Heart Study.

Authors:  Gary F Mitchell; Shih-Jen Hwang; Ramachandran S Vasan; Martin G Larson; Michael J Pencina; Naomi M Hamburg; Joseph A Vita; Daniel Levy; Emelia J Benjamin
Journal:  Circulation       Date:  2010-01-18       Impact factor: 29.690

6.  Cohort profile: Shahroud Eye Cohort Study.

Authors:  Akbar Fotouhi; Hassan Hashemi; Mohammad Shariati; Mohammad Hassan Emamian; Kamran Yazdani; Ebrahim Jafarzadehpur; Hassan Koohian; Mohammad Reza Khademi; Kamran Hodjatjalali; Ahmad Kheirkhah; Reza Chaman; Sarvenaz Malihi; Mehdi Mirzaii; Mehdi Khabazkhoob
Journal:  Int J Epidemiol       Date:  2012-10-17       Impact factor: 7.196

Review 7.  Growing epidemic of coronary heart disease in low- and middle-income countries.

Authors:  Thomas A Gaziano; Asaf Bitton; Shuchi Anand; Shafika Abrahams-Gessel; Adrianna Murphy
Journal:  Curr Probl Cardiol       Date:  2010-02       Impact factor: 5.200

8.  Association of cardiovascular burden with mobility limitation among elderly people: a population-based study.

Authors:  Anna-Karin Welmer; Sara Angleman; Elisabeth Rydwik; Laura Fratiglioni; Chengxuan Qiu
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

9.  Cardiovascular and non-cardiovascular hospital admissions associated with atrial fibrillation: a Danish nationwide, retrospective cohort study.

Authors:  Christine Benn Christiansen; Jonas Bjerring Olesen; Gunnar Gislason; Morten Lock-Hansen; Christian Torp-Pedersen
Journal:  BMJ Open       Date:  2013-01-24       Impact factor: 2.692

10.  Prospective relationship of low cardiovascular risk factor profile at younger ages to ankle-brachial index: 39-year follow-up--the Chicago Healthy Aging Study.

Authors:  Thanh-Huyen T Vu; Jeremiah Stamler; Kiang Liu; Mary M McDermott; Donald M Lloyd-Jones; Amber Pirzada; Daniel B Garside; Martha L Daviglus
Journal:  J Am Heart Assoc       Date:  2012-12-19       Impact factor: 5.501

View more
  23 in total

Review 1.  Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan.

Authors:  L Vandenput; H Johansson; E V McCloskey; E Liu; K E Åkesson; F A Anderson; R Azagra; C L Bager; C Beaudart; H A Bischoff-Ferrari; E Biver; O Bruyère; J A Cauley; J R Center; R Chapurlat; C Christiansen; C Cooper; C J Crandall; S R Cummings; J A P da Silva; B Dawson-Hughes; A Diez-Perez; A B Dufour; J A Eisman; P J M Elders; S Ferrari; Y Fujita; S Fujiwara; C-C Glüer; I Goldshtein; D Goltzman; V Gudnason; J Hall; D Hans; M Hoff; R J Hollick; M Huisman; M Iki; S Ish-Shalom; G Jones; M K Karlsson; S Khosla; D P Kiel; W-P Koh; F Koromani; M A Kotowicz; H Kröger; T Kwok; O Lamy; A Langhammer; B Larijani; K Lippuner; D Mellström; T Merlijn; A Nordström; P Nordström; T W O'Neill; B Obermayer-Pietsch; C Ohlsson; E S Orwoll; J A Pasco; F Rivadeneira; B Schei; A-M Schott; E J Shiroma; K Siggeirsdottir; E M Simonsick; E Sornay-Rendu; R Sund; K M A Swart; P Szulc; J Tamaki; D J Torgerson; N M van Schoor; T P van Staa; J Vila; N J Wareham; N C Wright; N Yoshimura; M C Zillikens; M Zwart; N C Harvey; M Lorentzon; W D Leslie; J A Kanis
Journal:  Osteoporos Int       Date:  2022-05-31       Impact factor: 5.071

2.  Studying the relationship between cognitive impairment and frailty phenotype: a cross-sectional analysis of the Bushehr Elderly Health (BEH) program.

Authors:  Farshad Sharifi; Mahtab Alizadeh Khoiee; Reihane Aminroaya; Mahbube Ebrahimpur; Gita Shafiee; Ramin Heshmat; Moloud Payab; Zhaleh Shadman; Hossein Fakhrzadeh; Seyed Masoud Arzaghi; Neda Mehrdad; Afshin Ostovar; Ali Sheidaei; Noushin Fahimfar; Iraj Nabipour; Bagher Larijani
Journal:  J Diabetes Metab Disord       Date:  2021-07-06

3.  The association between muscle indicators and bone mass density and related risk factors in the diabetic elderly population: Bushehr Elderly Health (BEH) Program.

Authors:  Marzieh Nikfarjam; Ramin Heshmat; Safoora Gharibzadeh; Afshin Ostovar; Vahid Maleki; Jalal Moludi; Iraj Nabipour; Gita Shafiee; Bagher Larijani
Journal:  J Diabetes Metab Disord       Date:  2021-08-25

4.  Comparison of anthro-metabolic indicators for predicting the risk of metabolic syndrome in the elderly population: Bushehr Elderly Health (BEH) program.

Authors:  Neda Rabiei; Ramin Heshmat; Safoora Gharibzadeh; Afshin Ostovar; Vahid Maleki; Mehdi Sadeghian; Saba Maleki Birjandi; Iraj Nabipour; Gita Shafiee; Bagher Larijani
Journal:  J Diabetes Metab Disord       Date:  2021-08-28

5.  Inverse association between cigarette and water pipe smoking and hypertension in an elderly population in Iran: Bushehr elderly health programme.

Authors:  M B Mehboudi; I Nabipour; K Vahdat; H Darabi; A Raeisi; N Mehrdad; R Heshmat; G Shafiee; B Larijani; A Ostovar
Journal:  J Hum Hypertens       Date:  2017-09-07       Impact factor: 3.012

6.  Effect of diabetes on BMD and TBS values as determinants of bone health in the elderly: Bushehr Elderly Health program.

Authors:  Mahbube Ebrahimpur; Farshad Sharifi; Farzaneh Amini Nezhad; Mohammad Bagherzadeh; Afshin Ostovar; Gita Shafiee; Ramin Heshmat; Neda Mehrdad; Faride Razi; Patricia Khashayar; Iraj Nabipour; Bagher Larijani
Journal:  J Diabetes Metab Disord       Date:  2019-03-09

7.  Comparison of EWGSOP-1and EWGSOP-2 diagnostic criteria on prevalence of and risk factors for sarcopenia among Iranian older people: the Bushehr Elderly Health (BEH) program.

Authors:  Gita Shafiee; Ramin Heshmat; Afshin Ostovar; Fatemeh Khatami; Noushin Fahimfar; Seyed Masoud Arzaghi; Safoora Gharibzadeh; Sara Hanaei; Iraj Nabipour; Bagher Larijani
Journal:  J Diabetes Metab Disord       Date:  2020-05-29

8.  Association between anemia, physical performance and cognitive function in Iranian elderly people: evidence from Bushehr Elderly Health (BEH) program.

Authors:  Maryam Marzban; Iraj Nabipour; Akram Farhadi; Afshin Ostovar; Bagher Larijani; Amir Hossein Darabi; Elnaz Shabankari; Mohamad Gholizade
Journal:  BMC Geriatr       Date:  2021-05-24       Impact factor: 3.921

9.  Grand multiparity associations with low bone mineral density and degraded trabecular bone pattern.

Authors:  Nekoo Panahi; Afshin Ostovar; Noushin Fahimfar; Safoora Gharibzadeh; Gita Shafiee; Ramin Heshmat; Alireza Raeisi; Iraj Nabipour; Bagher Larijani; Ali Ghasem-Zadeh
Journal:  Bone Rep       Date:  2021-04-22

10.  Prevalence of osteoporosis among the elderly population of Iran.

Authors:  Noushin Fahimfar; Sima Noorali; Shakiba Yousefi; Safoora Gharibzadeh; Gita Shafiee; Nekoo Panahi; Mahnaz Sanjari; Ramin Heshmat; Farshad Sharifi; Neda Mehrdad; Alireza Raeisi; Iraj Nabipour; Bagher Larijani; Afshin Ostovar
Journal:  Arch Osteoporos       Date:  2021-01-21       Impact factor: 2.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.